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Abstract—Cardiogoniometry (CGM) is method of 3-dimen-
sional electrocardiographic assessment which has been
shown to identify patients with angiographically deﬁned,
stable coronary artery disease (CAD). However, angio-
graphic evidence of CAD, does not always correlate to
physiologically signiﬁcant disease. The aim of our study was
to assess the ability of CGM to detect physiologically
signiﬁcant coronary stenosis deﬁned by fractional ﬂow
reserve (FFR). In a tertiary cardiology centre, elective
patients with single vessel CAD were enrolled into a
prospective double blinded observational study. A baseline
CGM recording was performed at rest. A second CGM
recording was performed during the FFR procedure, at the
time of adenosine induced maximal hyperaemia. A signiﬁ-
cant CGM result was deﬁned as an automatically calculated
ischaemia score < 0 and a signiﬁcant FFR ratio was deﬁned
as < 0.80. Measures of diagnostic performance (including
sensitivity and speciﬁcity) were calculated for CGM at rest
and during maximal hyperaemia. Forty-ﬁve patients were
included (aged 61.1 ± 11.0; 60.0% male), of which eighteen
(40%) were found to have signiﬁcant CAD when assessed by
FFR. At rest, CGM yielded a sensitivity of 33.3% and
speciﬁcity of 63.0%. At maximal hyperaemia the sensitivity
and speciﬁcity of CGM was 71.4 and 50.0% respectively. The
diagnostic performance of CGM to detect physiologically
signiﬁcant stable CAD is poor at rest. Although, the
diagnostic performance of CGM improves substantially
during maximal hyperaemia, it does not reach sufﬁcient
levels of accuracy to be used routinely in clinical practice.
Keywords—Cardiogoniometry, Fractional ﬂow reserve,
Coronary artery disease, Vectorcardiography, Diagnostic
accuracy.
INTRODUCTION
Non-invasive assessment is universally recom-
mended in the investigation of patients with suspected
stable coronary artery disease (CAD).5,10 However,
there is still an unmet need for a quick, easy and cost-
effective test which can exclude patients in a primary
care or outpatient setting, who do not require further
investigation.
Cardiogoniometry (CGM) is a method of 3-dimen-
sional electrocardiographic assessment which uses ﬁve
surface electrodes to produce a recording from three
virtual bipolar leads (see Fig. 1). Importantly, an
automated ischaemia scoring system that attributes a
numerical value to the CGM recording, has been
shown to have reasonable diagnostic performance at
identifying angiographically deﬁned, stable coronary
artery disease (CAD).7,13,20 In addition, previous work
has suggested the diagnostic performance of CGM is
increased during adenosine stress testing.19 Neverthe-
less, angiographic evidence of CAD does not always
correlate to physiologically signiﬁcant CAD.17
Fractional ﬂow reserve (FFR) is a technique used
during cardiac catheterisation to assess the physiolog-
ical signiﬁcance of coronary artery stenoses. FFR
works by comparing the ratio of blood ﬂow distal to a
coronary stenosis to normal ﬂow during maximal
hyperaemia.11 Previous work has shown that only 35%
of coronary stenoses classed angiographically as 50–
75% diameter stenosis are physiologically signiﬁcant.18
Importantly, FFR guided percutaneous coronary
intervention (PCI) has been shown to improve prog-
nosis in patients with stable CAD.17
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The aim of this prospective single centre, double
blinded observational study was to evaluate whether
non-invasive assessment with CGM could detect
physiologically signiﬁcant coronary stenosis deﬁned by
FFR, both at rest and during adenosine induced
maximal hyperaemia.
METHODOLOGY
Study Participants
Forty-ﬁve patients with single vessel CAD admitted
for elective PCI were consecutively recruited in a single
tertiary centre between January and October 2016.
For inclusion, patients had to be aged 18 years or
over and known to have single vessel CAD diagnosed
on previous coronary angiography. All patients pro-
vided informed consent to undergo coronary angiog-
raphy with pressure wire assessment ± PCI. Exclusion
criteria were: patients with an acute coronary syn-
drome (as deﬁned by the ESC15); patients unable to
tolerate adenosine; patients unable to perform a good
quality CGM; patients with atrial ﬁbrillation; patients
with haemodynamic instability and patients with pre-
vious coronary artery bypass graft surgery.
All subjects provided written informed consent to
the study prior to enrolment. The study protocol was
approved by the regional research ethics committee
(12/YH/0271) and registered on www.clinicaltrials.gov
, unique identiﬁer: NCT02815631. The research project
was conducted in accordance with the Declarations of
Helsinki.
Catheter Laboratory Protocol
A baseline CGM recording was performed in the
catheter laboratory once the patient was relaxed and
prior to commencing the invasive procedure. Radial or
femoral access was then gained and patients were
anticoagulated with 100 U/kg of heparin. A guide ca-
theter was advanced to the coronary ostia as per usual
clinical practice and coronary angiography performed
of both the right and left coronary systems following
administration of 200 mcg bolus of intra-coronary
glyceryl trinitrate. The coronary pressure wire was
advanced until the pressure sensor was aligned with the
tip of the guide catheter, whereby both pressures were
equalised. The coronary pressure wire was then ad-
vanced down the aﬀected coronary artery being
investigated and through the stenosis, where a bolus of
200 mcg of intracoronary glyceryl trinitrate was
administered. Resting FFR and a second CGM
recording were then performed. An intravenous ade-
nosine infusion (180 mg/kg/min) was administered
through a peripheral venous cannula in the antecubital
fossa for 3 min or until maximal hyperaemia had been
achieved. During maximal hyperaemia, peak FFR and
CGM recordings were made. OIB then left the room to
remain blinded to the result of the FFR assessment
and took the CGM recordings for interpretation. The
operating interventional cardiologist recorded the re-
sults of the FFR assessment and managed the patient
as per clinical practice.
Data Analysis
CGM data was recorded onto the Patient Explorer
software version 2.1 [Enverdis, Jena, Germany]. The
software automatically detects irregular or ectopic
beats in the recording and excludes them from the
analysis. All CGM recordings were interpreted by
OIB, who remained blinded to the result of FFR. For
each CGM tracing, the ischaemia score was recorded
as a dichotomous result: negative (ischaemia score =
0) or positive (ischaemia score < 0).13
FFR was classiﬁed dichotomously as negative
(FFR > 0.80) or positive (FFR £ 0.80) at baseline
and at maximal hyperaemia by the operating inter-
ventional cardiologist.17
Both the CGM and FFR results were stored on
separate encrypted electronic databases. At the end of
participant recruitment, blinding was broken and OIB
analysed the results of CGM (at rest and during
maximal hyperaemia) in comparison to FFR (at
maximal hyperaemia).
Quantitative coronary angiographic (QCA) analysis
was performed using Centricity Explorer system. The
reference vessel diameter, minimal lumen diameter
(MLD), percent diameter stenosis and lesion length
were measured before FFR assessment. Reference
FIGURE 1. Principles of Cardiogoniometry: (a) Showing
electrode placement: electrode 1 (green), Wilson position V4;
electrode 2 (white), Wilson position V8; electrode 3 (yellow),
directly superior to electrode 1 at a distance 0.7 times the
distance between electrode 1 and 2; electrode 4 (red), directly
right of electrode 3 at a distance the same as between elec-
trode 1 and 3. The following leads are defined by the following
electrodes: Anterior (A) by electrode 4 ﬁ 1; Horizontal (Ho)
by electrode 4 ﬁ 3; Vertical (Ve) by electrode 3 ﬁ 1; Infe-
rior by electrode 2 ﬁ 1 and Diagonal (D) by electrode 4 ﬁ 2
(see Fig. 1a). Triangles left of the thorax show the direction of
the aforementioned leads. (b) Showing the orientation of
orthogonal axes X, Y and Z in the thorax (left panel) and
trigonometric equations defining their formation (right panel);
(c) Showing the formation of vector loops by plotting of the
heart vector at every millisecond for the P (grey), QRS (blue)
and T waves (green), with maximum vectors for the P and QRS
loop (orange lines) being shown. Reproduced from To¨lg
et al.16
c
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vessel diameter was taken as the diameter of the nor-
mal vessel proximal to the lesion.
It has been previously proposed that the diagnostic
performance of CGM is driven by myocardial scarring,
as opposed to chronic reversible ischaemia.1,19 There-
fore, a pre-speciﬁed subgroup analysis for the diag-
nostic performance of CGM was patients without
previous myocardial infarction. Finally, to allow
comparison to previously published work, the diag-
nostic performance of CGM at rest was evaluated at
identifying ‡ 50 and ‡ 70% diameter stenosis (DS).
Statistical Analysis
IBM SPSS Statistics for Macintosh, Version 23.0
was used for statistical analysis. Descriptive statistics
were used to summarise the data. Baseline continuous
variables are expressed as mean ± SD or median with
interquartile range, categorical data was expressed as
numbers/percentages. Sensitivity, speciﬁcity, positive
predictive value (PPV) and negative predictive value
(NPV) were used to measure the diagnostic accuracy of
CGM in comparison to FFR. Statistical agreement
between CGM and FFR was calculated by the Kappa
statistic.3
RESULTS
Baseline and angiographic characteristics for the
study participants are shown in Tables 1 and 2
respectively. Eleven (24.4%) participants had previ-
ously had a myocardial infarction and 16 (35.6%) had
previously received PCI. The majority of lesions were
located in the left anterior descending artery (77.8%).
At baseline, 16 (35.6%) participants had a positive
CGM result which increased to 24 (53.3%) during
maximal hyperaemia. Of the forty-ﬁve patients re-
cruited in our study, eighteen (40%) were found to
have signiﬁcant coronary artery disease when assessed
by FFR.
Diagnostic Performance of CGM
The diagnostic performance of CGM to detect
physiologically signiﬁcant stenosis is shown in Table 3.
At rest, the diagnostic performance of CGM was poor
across all measures. During maximal hyperaemia the
sensitivity of CGM signiﬁcantly increased compared to
rest (33.3 vs. 71.4%). However, a concomitant reduc-
tion in speciﬁcity was also observed (63.0 vs. 50.0%).
PPV and NPV were also increased at maximal hyper-
aemia compared to at rest. No statistical agreement
between CGM and FFR was found at rest
(j =  0.04, p = 0.80). A fair agreement between
CGM and FFR was seen during maximal hyperaemia,
but this was not statistically signiﬁcant (j = 0.21,
p = 0.14).
TABLE 1. Baseline characteristics of participants in CAR-
DIOFLOW.
Demographics
N 45
Male (%) 24 (53.3)
Age (SD) 61.4 (10.9)
Body mass index (SD) 30.5 (6.3)
Past medical history (%)
Myocardial infarction 11 (24.4)
Percutaneous coronary intervention 16 (35.6)
Stroke/transient ischaemic attack 3 (6.7)
Diabetes mellitus 8 (17.8)
Hypertension 26 (57.8)
Hypercholesterolaemia 26 (57.8)
Smoking (never/ex/current) 16 (35.6)/19 (42.2)/
10 (22.2)
Medication at enrollment (%)
Aspirin 42 (93.3)
Clopidogrel 9 (20.0)
Ticagrelor 7 (15.6)
ACE inhibitor 13 (28.9)
Angiotensin receptor blocker 9 (20.0)
b-blocker 33 (73.3)
Ca2+ channel blocker 12 (26.7)
Lipid lowering drug 35 (77.8)
Baseline blood results
Haemoglobin, g/L (SD) 141.4 (12.3)
Sodium, mmol/L (SD) 137.5 (2.3)
Potassium, mmol/L (SD) 4.3 (0.3)
Urea, mmol/L (SD) 5.9 (1.7)
Creatinine, mmol/L (SD) 78.8 (17.6)
Continuous data is expressed with its mean and standard deviation
(SD).
TABLE 2. Showing the angiographic and fractional flow re-
serve (FFR) characteristics of study participants.
Angiographic details
Stenosis site (%)
LAD 35 (77.8)
RCA 4 (8.9)
LCX 3 (6.7)
OM 1 (2.2)
D 2 (4.4)
Stent implanted (% yes) 17 (37.8)
Reference vessel diameter (± SD) 2.96 ± 0.68 mm
Minimal luminal diameter (± SD) 1.27 ± 0.48 mm
% diameter stenosis (± SD) 56.90 ± 15.34
Lesion length (± SD) 18.49 ± 13.61 mm
FFR details
Rest FFR (± SD) 0.90 ± 0.12
Peak hyperaemia FFR (± SD) 0.81 ± 0.13
Positive FFR at rest (%) 3 (6.7)
Positive FFR during hyperaemia (%) 18 (40.0)
Stenosis site is categorised into left anterior descending artery
(LAD); right coronary artery (RCA); left circumflex artery (LCx);
obtuse marginal artery (OM) and diagonal artery (D). Continuous
data is expressed with its mean and standard deviation (SD).
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The results of the subgroup analysis of patients
without history of myocardial infarction is found in
Appendix 1.
The diagnostic performance of CGM to detect CAD
deﬁned by % DS is shown in Table 4.
DISCUSSION
The diagnostic performance of CGM to detect
patients with physiologically signiﬁcant stable CAD is
poor at rest. Although, the diagnostic performance of
CGM improves with the administration of intravenous
adenosine, it does not reach suﬃcient levels of accu-
racy to safely exclude patients without physiologically
signiﬁcant stable CAD.
One of the main objectives of this study was to see if
CGM had adequate sensitivity to safely stratify
patients who required FFR assessment, avoiding the
additional cost of the pressure wires and increased
procedural risks. However, even during maximal
hyperaemia the sensitivity of CGM was not high en-
ough to be relied upon. For every hundred patients
with physiologically signiﬁcant stable CAD tested,
CGM would not detect the presence of stable CAD in
twenty-nine of those patients.
The reported ﬁgures for the measures of diagnostic
performance of CGM in this study are considerably
worse than previously published work which used
coronary angiography to deﬁne CAD.7,13,14,20 In pre-
viously published CGM studies, CGM demonstrated
greater sensitivity (64–72%) and speciﬁcity (60–82%)
when ‡ 50% DS was used to deﬁne signiﬁcant CAD
then seen in our results. Furthermore, previous CGM
studies which used ‡ 70% DS to deﬁne signiﬁcant
CAD, also reported a higher sensitivity (75–84%) and
speciﬁcity (74–81%) than results seen in our study.13,14
The difference in diagnostic performance of CGM in
our study compared to previously published work may
be because the pre-test probability of having angio-
graphic CAD was greater in our study, as the patients
were known to have angiographic evidence of disease
prior to being enrolled.
One major issue of the automated algorithm used by
the CGM device is that when it was originally vali-
dated, it was based on data from a study where
patients were classiﬁed as having stable CAD based
only on coronary angiography (deﬁned as ‡ 50%
diameter stenosis).13 This is a fundamental ﬂaw of the
device algorithm, as % diameter stenosis is not a reli-
able method of detecting signiﬁcant lesions causing
ischaemia.17 This may explain the low speciﬁcity seen
in our study, as the cardiogoniometric variables it
classes as being present in patients with stable CAD
are not sufﬁciently speciﬁc for physiologically signiﬁ-
cant coronary disease. Nevertheless, it should be stated
that CGM was ﬁrst developed before the routine use of
FFR. Therefore, it is not unreasonable that its initial
development was based on the ability of CGM to de-
tect angiographically signiﬁcant coronary stenoses,
and not FFR signiﬁcant stenosis.
All of the previously published work did not limit
study participants to having single vessel disease and
this may also contribute to explaining the observed
diﬀerences in results. The diagnostic performance of
CGM may be greater in patients with multi-vessel
disease as they may have a greater ischaemic burden.
Furthermore, patients with multi-vessel disease tend to
have worse long term outcome, increased procedural
risk and signiﬁcant comorbidities.4 Nevertheless, this is
the only study investigating CGM using FFR, a robust
method of identifying physiologically signiﬁcant
myocardial ischaemia.
The diagnostic performance of CGM in this study
was considerably worse than other methods of non-
invasive physiological assessment of coronary ischae-
mia, including stress echocardiography and myocar-
dial perfusion imaging (MPI).6,12 However, when these
methods of physiological assessment have been
assessed using FFR as the gold standard, they have
been shown to have poor agreement with FFR to de-
tect physiologically signiﬁcant stable CAD.8,9 Re-
ported ﬁgures in the literature of the sensitivity and
TABLE 3. Diagnostic performance of cardiogoniometry
(CGM) to detect physiologically significant coronary stenosis.
CGM at
rest (n = 45)
CGM during maximal
hyperaemia (n = 45)
Sensitivity 33.3% 71.4%
Specificity 63.0% 50.4%
Positive predicative
value
37.5% 55.6%
Negative predicative
value
58.6% 66.7%
Kappa statistic for
agreement
 0.04, p = 0.80 0.21, p = 0.14
TABLE 4. Diagnostic performance of cardiogoniometry
(CGM) to detect stable coronary artery disease defined as ei-
ther ‡ 50% diameter stenosis (DS) or ‡ 70% DS.
Definition of stable CAD
CGM
‡ 50% DS ‡ 70% DS
Sensitivity 38.5% 16.7%
Specificity 70.0% 56.7%
Positive predicative
value
76.9% 14.3%
Negative predicative
value
30.4% 77.3%
Kappa statistic for
agreement
0.06, p = 0.64  0.174, p = 0.22
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speciﬁcity of stress echocardiography at identifying
FFR-deﬁned CAD are 50 and 90% respectively.8 MPI
with SPECT has also been shown to perform poorly,
with a sensitivity and speciﬁcity of 76 and 38% at
identifying FFR-deﬁned CAD.9 Of note, MPI with
SPECT has been shown to overestimate FFR-deﬁned
ischaemia in 22% of participants and underestimate it
in 36% of participants. An argument could be made
that it is inappropriate to critique SPECT against
FFR, as FFR was ﬁrst validated against SPECT.11
However, since its validation, FFR based decision
making has been shown to improve clinical endpoints
and as such, can be taken as a reliable and robust
method for identifying signiﬁcant coronary stenoses.17
It is therefore difﬁcult to criticise the diagnostic per-
formance of CGM on the basis of other non-invasive
methods of physiological ischaemia assessment.
It has previously been proposed that the diagnostic
performance of CGM could be driven by detection of
myocardial scarring, as opposed to chronic reversible
ischaemia.1,19 It would be expected that the speciﬁcity
of CGM would be reduced by myocardial scarring.
However the results of this study have demonstrated
that there were no signiﬁcant differences in the speci-
ﬁcity or sensitivity of CGM when patients with previ-
ous MI are excluded (Appendix 1). This correlates
with previously published work, and we can therefore
be conﬁdent that myocardial scarring does not have a
big inﬂuence on the diagnostic performance of
CGM.19
It would have been interesting to see if other
stressing agents like dobutamine, may have increased
the sensitivity of CGM. Dobutamine, a b1 adrenergic
receptor agonist, acts by directly raising the metabolic
demands of the myocardium by increasing heart rate
and the force of cardiac contractility. Whereas the
mechanism by which adenosine may induce ischaemia
is less deﬁned. It is likely indirect, and may be due to its
ability to produce a coronary steal effect.2 As patients
were already undergoing pharmacological stress with
intravenous adenosine as part of their clinical care, it
was felt to be unethical to subject them to an addi-
tional CGM stress test and induce the unpleasant side
effects associated with dobutamine (nausea, headaches
and dyspnoea). One previous study reports similar
ﬁgures seen in this study for the sensitivity and speci-
ﬁcity of CGM during adenosine stress.19 However, the
authors of this study used SPECT to conﬁrm the
presence of stable CAD, which as previously men-
tioned is not a robust method of quantifying physio-
logical signiﬁcance. Interestingly, this previous study
also showed a reduction in the speciﬁcity of CGM,
when patients underwent pharmacological stress with
intravenous adenosine.
CARDIOFLOW was designed to be as clinically
applicable as possible, therefore the interpretation of
the CGM result was based solely on the automated
ischaemia score alone, and not by review of the raw
data by an experienced CGM reporter. The idea being
that, if CGM were to be implemented into routine
clinical practice, a recording could be performed by an
operator without detailed knowledge of CGM. Our
patients are typical of routine clinical practice, a
reﬂection of our consecutive recruitment of partici-
pants and reduction of the risk of selection bias. Fur-
thermore, there was a wide range in both the length
and severity of the lesions in the participants recruited
in our study. This again mirrors the picture seen in
routine clinical practice and increases the external
validity of the study
Study Limitations
This was a single centre study and only enrolled a
relatively small number of participants. In addition to
this, patients with multi-vessel disease, atrial ﬁbrillation
or previous CABG were excluded. Myocardial scarring
was assumed in patients with previous MI and not for-
mally assessed by performing cardiac MRI with late
gadolinium enhancement; therefore, patients may have
been incorrectly excluded from the subgroup analysis.
Additional testing of participants with stress echocar-
diography and myocardial perfusion imaging would
have allowed direct comparison between CGM and
other methods of assessment, however this was not
performed as it is not part of their routine clinical care.
Finally, the operator performing CGMwas not blind to
the results of coronary angiography which could have
inﬂuenced their interpretation. However, the result gi-
ven by CGM is automated and dichotomous (i.e. cate-
gorically positive or negative) and therefore the impact
of seeing coronary angiography would have been low.
CONCLUSIONS
The diagnostic performance of CGM to detect
physiologically signiﬁcant stable CAD is poor at rest.
Although, the diagnostic performance of CGM im-
proves substantially during adenosine stress testing, it
does not reach suﬃcient levels of accuracy to be used
routinely in clinical practice.
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APPENDIX 1
See Table 5.
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